LIFECORE BIOMEDICAL, INC. \DE\·4

Apr 16, 4:39 PM ET

Salus Thomas D. 4

4 · LIFECORE BIOMEDICAL, INC. \DE\ · Filed Apr 16, 2026

Research Summary

AI-generated summary of this filing

Updated

Lifecore (LFCR) Chief Legal & Administration Thomas D. Salus Withholds 24,645 Shares

What Happened
Thomas D. Salus, Lifecore Biomedical's Chief Legal & Administration, had 24,645 shares withheld by the company to satisfy tax withholding obligations related to the vesting and settlement of RSUs. The withholding occurred on 2026-04-14 at $5.20 per share, totaling $128,154. This was a tax-withholding disposition (not an open-market sale).

Key Details

  • Transaction date: 2026-04-14; filing date (Form 4): 2026-04-16 (timely within the usual two-business-day window).
  • Instrument/transaction code: F (payment of exercise price or tax liability) — shares were disposed/withheld.
  • Count and price: 24,645 shares withheld at $5.20 each; total value ≈ $128,154.
  • Footnote: F1 — shares withheld by the issuer to satisfy tax withholding for RSU vesting/settlement.
  • Shares owned after transaction: Not specified in the provided filing data.

Context
This was a routine cashless tax-withholding action associated with RSU vesting: the company retained (disposed of) a portion of vested shares to pay taxes on behalf of the insider. Such withholdings are administrative and do not necessarily indicate intent to sell additional shares in the market.

Insider Transaction Report

Form 4
Period: 2026-04-14
Salus Thomas D.
Chief Legal & Administration
Transactions
  • Tax Payment

    Common Stock

    [F1]
    2026-04-14$5.20/sh24,645$128,154246,333 total
Footnotes (1)
  • [F1]Represents number of shares withheld by the issuer to satisfy applicable tax withholding obligations in connection with the vesting and settlement of an RSU vesting.
Signature
/s/ Aaron S. Perlitsh, Attorney-In-Fact for Thomas D Salus|2026-04-16

Documents

1 file
  • 4
    wk-form4_1776371972.xmlPrimary

    FORM 4